Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Fungal Allergenic Extract [EPC]
Reishi (Ganoderma lucidum) is a complex fungal substance classified as a Non-Standardized Fungal Allergenic Extract, used clinically for diagnostic allergy testing and studied for its potent immunomodulatory effects on interferon and lymphocyte pathways.
Name
Reishi
Raw Name
REISHI
Category
Non-Standardized Fungal Allergenic Extract [EPC]
Drug Count
7
Variant Count
7
Last Verified
February 17, 2026
About Reishi
Reishi (Ganoderma lucidum) is a complex fungal substance classified as a Non-Standardized Fungal Allergenic Extract, used clinically for diagnostic allergy testing and studied for its potent immunomodulatory effects on interferon and lymphocyte pathways.
Detailed information about Reishi
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Reishi.
Reishi, scientifically known as Ganoderma lucidum, is a polypore fungus that has been utilized for millennia in traditional Eastern medicine. In the context of modern clinical pharmacology, Reishi is categorized primarily as a Non-Standardized Fungal Allergenic Extract [EPC]. It also falls under the classifications of Non-Standardized Food Allergenic Extract [EPC], and it is recognized for its biological activity as an Interferon gamma [EPC] inducer and a Lymphocyte Growth Factor [EPC] modulator. Unlike standardized medications with a single active pharmaceutical ingredient, Reishi is a complex biological matrix containing over 400 bioactive compounds, including triterpenoids, polysaccharides, nucleotides, sterols, steroids, fatty acids, and proteins.
In the United States, Reishi extracts are utilized in clinical immunology for the diagnosis and potentially the treatment of fungal hypersensitivity (allergies). As a 'non-standardized' extract, its potency is not measured by a specific bioassay or weight-of-unit, but rather by the concentration of the raw material used during the extraction process (e.g., a 1:10 or 1:20 w/v ratio). The FDA has a long history of regulating allergenic extracts under the Public Health Service Act, ensuring that these biological products meet specific safety and purity standards, even when 'standardization' (the ability to measure a specific active unit) is not yet feasible for the specific fungal species.
Beyond its use in allergy clinics, Reishi is widely studied for its 'adaptogenic' properties—a non-clinical term used to describe substances that may help the body maintain homeostasis (internal balance). From a pharmacological perspective, this is attributed to its role as a lymphocyte growth factor, which helps regulate the proliferation of T and B cells, and its ability to stimulate the production of Interferon-gamma, a critical cytokine (cell-signaling protein) involved in the innate and adaptive immune response against viral and intracellular bacterial pathogens.
The mechanism of action for Reishi is multi-faceted and depends heavily on the fraction of the fungus being utilized (e.g., the fruiting body, spores, or mycelium). At the molecular level, the primary active constituents are beta-glucans (polysaccharides) and ganoderic acids (triterpenes).
Reishi is utilized in several clinical and therapeutic contexts:
Reishi is available in various preparations, though the clinical 'extract' used for allergy testing is distinct from consumer products:
> Important: Only your healthcare provider can determine if Reishi is right for your specific condition. Clinical allergenic extracts must only be administered by trained professionals in a facility equipped to handle anaphylaxis.
Dosage for Reishi varies significantly based on the intended use and the specific formulation. Because it is a 'non-standardized' extract, there is no single 'correct' dose. However, clinical literature and traditional use provide the following ranges:
Reishi is not approved for general use in children without strict medical supervision. In the context of allergy testing, pediatric dosing is determined by the allergist based on the child's age and sensitivity. For oral use, safety and efficacy have not been established in patients under 18 years of age. Some practitioners may use weight-based dosing (e.g., Clark’s Rule), but this is not supported by robust clinical trials.
There are no specific guidelines for Reishi dosage in patients with kidney disease. However, because some metabolites are excreted renally, patients with a GFR (Glomerular Filtration Rate) below 30 mL/min should use extreme caution. Lower doses may be necessary to prevent accumulation of fungal metabolites.
Reishi has been associated with rare cases of hepatotoxicity (liver damage). Patients with pre-existing liver disease (cirrhosis, hepatitis) should avoid Reishi unless specifically directed by a hepatologist. If used, frequent monitoring of liver enzymes (ALT, AST, Bilirubin) is mandatory.
Geriatric patients often have reduced organ reserve and may be taking multiple medications (polypharmacy). Dosing should start at the lowest end of the therapeutic range (e.g., 500 mg of crude powder) to assess tolerance and minimize the risk of interactions or side effects like dizziness.
If you miss a dose of an oral Reishi supplement, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular schedule. Do not double the dose to 'catch up.' For missed immunotherapy injections, contact your allergist immediately, as the 'build-up' schedule may need to be adjusted to prevent a reaction.
Signs of a Reishi overdose may include extreme dryness of the mouth, nose, and throat; severe gastrointestinal distress (diarrhea, cramping); or unexplained bruising and bleeding. In the event of a suspected overdose, contact your local poison control center or seek emergency medical care. There is no specific antidote for Reishi toxicity; treatment is supportive and symptomatic.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance. The potency of Reishi can vary wildly between brands, making professional oversight essential.
Most patients tolerate Reishi well, but the following common side effects may occur, particularly during the first two weeks of use as the body adjusts:
> Warning: Stop taking Reishi and call your doctor immediately if you experience any of these:
With prolonged use (exceeding 3 to 6 months), the risk of certain side effects may increase:
No FDA black box warnings currently exist for Reishi (Ganoderma lucidum). However, the FDA requires all allergenic extracts to carry warnings regarding the risk of systemic allergic reactions and the necessity of administration by qualified personnel.
Report any unusual symptoms to your healthcare provider. Side effects can be reported to the FDA at 1-800-FDA-1088 or through the MedWatch program.
Reishi is a potent biological agent and must be treated with the same caution as synthetic pharmaceuticals. Because it is a Non-Standardized Fungal Allergenic Extract, the concentration of active proteins and triterpenes can vary. Patients should never switch brands or formulations without consulting their healthcare provider, as this can lead to unexpected changes in efficacy or safety.
No FDA black box warnings for Reishi. However, clinical extracts used for testing are subject to standard warnings for allergenic products regarding the potential for life-threatening anaphylaxis.
If you are taking Reishi long-term (more than 4 weeks), your healthcare provider may require the following tests:
Reishi may cause dizziness or lightheadedness in some individuals. Do not drive or operate heavy machinery until you know how Reishi affects you. These effects are most common during the first few days of treatment.
Alcohol should be avoided or strictly limited while taking Reishi. Both alcohol and Reishi are processed by the liver; combining them increases the metabolic burden on the liver and may heighten the risk of hepatotoxicity. Additionally, alcohol can exacerbate the blood-thinning effects of Reishi.
There is no known 'withdrawal syndrome' associated with Reishi. However, if you are using it for immune modulation, stopping suddenly may result in a return of previous symptoms (e.g., fatigue or allergy flare-ups). It is generally recommended to taper the dose over one week if you have been taking high doses for an extended period.
> Important: Discuss all your medical conditions with your healthcare provider before starting Reishi. Ensure they are aware of any history of liver disease, bleeding disorders, or autoimmune conditions.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete medication reconciliation is the only way to prevent dangerous interactions.
Reishi must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis by a physician:
Patients allergic to the following may also react to Reishi:
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Reishi. Do not self-initiate Reishi if you fall into any of the categories above.
Reishi is classified as Category C (using the older FDA system, as specific modern data is lacking). There are no adequate and well-controlled studies of Reishi in pregnant women. Animal studies have not sufficiently evaluated its teratogenic (birth defect-causing) potential. Because Reishi can affect blood pressure, blood sugar, and immune function—all of which are tightly regulated during pregnancy—its use is not recommended during any trimester. There is a theoretical risk that its immunomodulatory effects could interfere with the maternal-fetal immune tolerance necessary to maintain a healthy pregnancy.
It is unknown whether Reishi metabolites are excreted in human milk. Many of the bioactive compounds, such as triterpenoids, are small enough that passage into breast milk is likely. The effects on a nursing infant’s developing immune system and liver are unknown. To avoid potential risks of hypersensitivity or toxicity in the infant, breastfeeding mothers should avoid Reishi products.
Safety and effectiveness in pediatric patients have not been established. While Reishi is used in clinical allergy testing for children, its use as a supplement or therapeutic agent is discouraged. Children’s immune systems are still developing, and the use of a Lymphocyte Growth Factor [EPC] like Reishi could theoretically interfere with natural immune maturation. If a physician deems it necessary, dosing must be strictly supervised and based on the child's weight and clinical status.
Clinical studies often exclude patients over the age of 65, but general pharmacological principles apply. Elderly patients are more likely to have age-related declines in renal and hepatic function, increasing the risk of Reishi accumulation. There is also an increased risk of falls due to potential dizziness or hypotension. Geriatric patients taking anticoagulants for atrial fibrillation or stroke prevention must be particularly careful, as the interaction with Reishi can be profound.
In patients with moderate to severe renal impairment, the clearance of water-soluble polysaccharides may be reduced. While no specific dose adjustments are codified, a 50% reduction in the starting dose is often suggested in clinical practice for those with a CrCl < 50 mL/min. Monitoring for signs of toxicity is essential.
Reishi is contraindicated in patients with severe hepatic impairment (Child-Pugh Class C). In mild to moderate impairment (Class A or B), it should be used with extreme caution. The liver is the primary site for the metabolism of ganoderic acids; impaired function can lead to significantly higher systemic exposure and increased risk of adverse effects.
> Important: Special populations require individualized medical assessment. Always consult a specialist before using Reishi in these groups.
Reishi (Ganoderma lucidum) functions as a complex biological response modifier. Its primary molecular targets include:
| Parameter | Value (Triterpenoids) |
|---|---|
| Bioavailability | 5% - 15% (Low) |
| Protein Binding | 70% - 85% |
| Half-life | 0.6 - 2.1 hours |
| Tmax | 0.5 - 1.5 hours |
| Metabolism | Hepatic (Phase I & II) |
| Excretion | Fecal 80%, Renal 20% |
Reishi belongs to the therapeutic class of Immunomodulators and the specific EPC class of Non-Standardized Fungal Allergenic Extracts. It is related to other medicinal fungi like Lentinula edodes (Shiitake) and Grifola frondosa (Maitake), though it possesses a unique profile of triterpenoid acids not found in other species.
Common questions about Reishi
Reishi is primarily used in clinical settings as a non-standardized fungal allergenic extract for diagnosing and treating mushroom or mold allergies through immunotherapy. In broader therapeutic contexts, it is used as an immunomodulator to support the immune system, particularly in patients experiencing fatigue or those seeking adjunctive support during chronic illness. It is classified as a lymphocyte growth factor and an interferon-gamma inducer, meaning it helps regulate and activate white blood cells. While popular in traditional medicine for longevity and stress, these uses are considered supportive rather than curative. Always consult a healthcare provider to see if Reishi is appropriate for your specific health needs.
The most frequently reported side effects of Reishi include dryness of the mouth, throat, and nasal passages, which can be bothersome for some users. Gastrointestinal issues such as nausea, stomach upset, and changes in bowel habits like diarrhea are also common, especially when starting the supplement. Some individuals may experience dizziness or a mild skin rash as their body adjusts to the fungal proteins. Because Reishi has mild blood-thinning properties, occasional nosebleeds may occur. Most of these symptoms are mild and resolve with continued use or by taking the supplement with food.
It is strongly advised to avoid or significantly limit alcohol consumption while taking Reishi. Both Reishi and alcohol are metabolized by the liver, and combining them can place excessive stress on this organ, potentially increasing the risk of liver toxicity or inflammation. Furthermore, alcohol can enhance the blood-thinning effects of Reishi, which may increase your risk of bruising or bleeding. Alcohol can also interfere with the immune-modulating effects that Reishi is intended to provide. For your safety, discuss your alcohol intake with your doctor before starting any fungal extract.
Reishi is generally not recommended for use during pregnancy due to a lack of comprehensive safety data in humans. There are concerns that its potent effects on the immune system could interfere with the delicate immunological balance required to maintain a healthy pregnancy. Additionally, Reishi's ability to lower blood pressure and blood sugar could pose risks to both the mother and the developing fetus. Because it is a complex biological product, the risk of contaminants or unpredictable reactions is higher than with standardized medications. Pregnant women should always prioritize FDA-approved prenatal care and avoid herbal extracts like Reishi unless specifically directed by an obstetrician.
The time it takes for Reishi to produce noticeable effects depends on the condition being addressed. For immune system modulation, clinical studies suggest that it typically takes 2 to 4 weeks of consistent daily use to see changes in cytokine levels or white blood cell activity. If used for fatigue or general well-being, some patients report improvements within the first 10 to 14 days. However, for allergy desensitization (immunotherapy), the process is much slower, often requiring months of gradually increasing doses to achieve effectiveness. Consistency is key, but you should not continue use indefinitely without medical supervision.
Yes, you can generally stop taking oral Reishi supplements suddenly without experiencing a physical withdrawal syndrome like those seen with opioids or benzodiazepines. However, if you have been using Reishi to manage chronic symptoms like fatigue or allergies, those symptoms may return once the active compounds leave your system. If you are undergoing clinical allergy immunotherapy with Reishi extracts, you must never stop the treatment without consulting your allergist, as this can disrupt your desensitization schedule. For high-dose supplement users, a brief tapering period of one week is often recommended to monitor how the body responds to the removal of the extract.
If you miss a dose of your Reishi supplement, take it as soon as you remember, provided it is not almost time for your next scheduled dose. If you are close to your next dose, simply skip the missed one and continue with your regular routine; never take two doses at once to make up for a mistake. Doubling the dose increases the risk of side effects like gastrointestinal distress or dizziness. If you miss an appointment for a Reishi-based allergy injection, call your doctor's office immediately to reschedule. Timely administration is crucial for the safety and success of allergy immunotherapy.
There is currently no clinical evidence to suggest that Reishi causes weight gain in humans. In fact, some preliminary animal studies suggest that Reishi extracts might support metabolic health and potentially help prevent weight gain associated with high-fat diets by modulating the gut microbiome. However, these effects have not been proven in human clinical trials. If you experience sudden or unexplained weight gain while taking Reishi, it is likely unrelated to the supplement and should be evaluated by your healthcare provider. Always maintain a balanced diet and exercise regimen regardless of the supplements you take.
Reishi has the potential for significant interactions with several classes of medications, making professional oversight essential. It can enhance the effects of blood thinners (anticoagulants) and blood pressure medications, potentially leading to excessive bleeding or dangerously low blood pressure. It may also interfere with immunosuppressant drugs used for organ transplants or autoimmune diseases by stimulating the immune system. Additionally, because it can lower blood sugar, it may interact with diabetes medications. Always provide your doctor with a full list of your current medications before starting Reishi to ensure there are no dangerous overlaps.
The concept of 'generic' vs. 'brand name' does not apply to Reishi in the same way it does to synthetic drugs. Since Reishi is a natural fungal product, it is sold by many different manufacturers under various brand names. However, in the clinical world of allergenic extracts, different laboratories may produce their own versions of 'Non-Standardized Fungal Allergenic Extract, Ganoderma lucidum.' These are not considered bioequivalent (exactly the same), so you should not switch between different manufacturers' extracts during a course of treatment. Always stick with the specific product recommended or provided by your healthcare professional.